You can buy or sell Myomo and other stocks, options, ETFs, and crypto commission-free!
Myomo Inc., also called Myomo, is a medical robotics company, which offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It offers MyoPro, which is a myoelectric elbow, wrist, and hand orthosis that supports an impaired hand and arm while also enabling it to move again. Read More The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Seeking AlphaMay 13
Myomo, Inc. CEO Paul Gudonis on Q1 2019 Results - Earnings Call Transcript
Myomo, Inc. (NYSEMKT:MYO) Q1 2019 Results Conference Call May 13, 2019 8:30 AM ET Company Participants Vivian Cervantes - IR Paul Gudonis - Chairman and CEO Dave Henry - CFO Conference Call Participants Jim Sidoti - Sidoti and Company Alex Silverman - AWM Investments Operator Good morning. And welcome to the Myomo Incorporated First Quarter 2019 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note that this event is being recorded. I would now like to tu...
Yahoo FinanceMay 13
Myomo, Inc. Reports Q1 Loss, Lags Revenue Estimates
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 15.00% and -3.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Myomo, Inc. (MYO) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 15%. A quarter ago, it was expected...
Yahoo FinanceMay 1
Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
The market expects Myomo, Inc. (MYO) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if t...
-$0.20 per share
-$0.17 per share